IDH1 and neoplasm: Differential methylation analysis showed that in all four tumor specific comparisons, IDH1/2 mutated tumors had a significantly higher number of hypermethylated gene body and enhancer probes than promoters and significantly higher number of hypomethylated promoter probes than gene bodies and enhancers (Fig. 1, Supp.